Rozel 60mg Denosumab Injection

Rozel 60mg Denosumab Injection is a prescription medication used to treat osteoporosis and other bone-related conditions in individuals who are at an increased risk of fractures. It contains Denosumab, a monoclonal antibody that works by inhibiting RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand), a protein involved in bone breakdown. By reducing bone resorption, Rozel 60mg Denosumab Injection helps improve bone mineral density, strengthen bones, and lower the risk of fractures. Administered as a subcutaneous injection under the supervision of a healthcare professional, it is commonly used as part of a long-term bone health management plan. Regular monitoring of calcium levels and bone density is recommended during treatment to ensure safe and effective use. Patients should use Rozel 60mg Injection only as prescribed by their healthcare provider.